Global Electronic Drug Delivery Systems Market to reach USD 14.1 billion by 2026.

Global Electronic Drug Delivery Systems Market Size study, by Type (Electronic Wearable Infusion Pump, Autoinjectors, Injection Pens, Electronic Inhalers), by Indication (Diabetes, Multiple Sclerosis, Cardiovascular Disease, Asthma & COPD) and Regional Forecasts 2019-2026
Product Code:  HALMDAE_20716822
Chapter 1.	Executive Summary 
1.1.	Market Snapshot
1.2.	Key Trends
1.3.	Global & Segmental Market Estimates & Forecasts, 2016-2026 (USD Billion)
1.3.1.	Electronic Drug Delivery Systems Market, by Type, 2016-2026 (USD Billion)
1.3.2.	Electronic Drug Delivery Systems Market, by Indication, 2016-2026 (USD Billion)
1.3.3.	Electronic Drug Delivery Systems Market, by Region, 2016-2026 (USD Billion)
1.4.	Estimation Methodology
1.5.	Research Assumption
Chapter 2.	Global Electronic Drug Delivery Systems Market Definition and Scope 
2.1.	Objective of the Study
2.2.	Market Definition & Scope
2.2.1.	Industry Evolution
2.2.2.	Scope of the Study
2.3.	Years Considered for the Study
2.4.	Currency Conversion Rates
Chapter 3.	Global Electronic Drug Delivery Systems Market Dynamics	
3.1.	See Saw Analysis
3.1.1.	Market Drivers
3.1.2.	Market Challenges
3.1.3.	Market Opportunities
Chapter 4.	Global Electronic Drug Delivery Systems Market Industry Analysis
4.1.	Porter’s 5 Force Model
4.1.1.	Bargaining Power of Buyers
4.1.2.	Bargaining Power of Suppliers
4.1.3.	Threat of New Entrants
4.1.4.	Threat of Substitutes
4.1.5.	Competitive Rivalry
4.1.6.	Futuristic Approach to Porter’s 5 Force Model
4.2.	PEST Analysis
4.2.1.	Political Scenario
4.2.2.	Economic Scenario
4.2.3.	Social Scenario
4.2.4.	Technological Scenario
4.3.	Key Buying Criteria (On Demand)
4.4.	Regulatory Framework (On Demand)
4.5.	Investment Vs Adoption Scenario (On Demand)
4.6.	Analyst Recommendation & Conclusion
Chapter 5.	Global Electronic Drug Delivery Systems Market, by Type          
5.1.	Market Snapshot 
5.2.	Market Performance - Potential Model
5.3.	Electronic Drug Delivery Systems Market, Sub Segment Analysis
5.3.1.	  Electronic Wearable Infusion Pumps
5.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.	  Electronic Autoinjectors
5.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.	  Electronic Injection Pens
5.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
5.3.4.	  Electronic Inhalers
5.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
5.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 6.	Global Electronic Drug Delivery Systems Market, by Indication          
6.1.	Market Snapshot 
6.2.	Market Performance - Potential Model
6.3.	Electronic Drug Delivery Systems Market, Sub Segment Analysis
6.3.1.	  Diabetes
6.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.1.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.	   Multiple Sclerosis
6.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.2.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.	   Cardiovascular Disease
6.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.3.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.	   Asthma & COPD
6.3.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.4.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
6.3.5.	   Other Indications
6.3.5.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
6.3.5.2.	Regional breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 7.	Global Electronic Drug Delivery Systems Market, by Regional Analysis
7.1.	Electronic Drug Delivery Systems Market, Regional Market Snapshot (2016-2026)
7.2.	North America Electronic Drug Delivery Systems Market Snapshot
7.2.1.	U.S.
7.2.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.1.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.	Canada
7.2.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.2.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)  
7.2.2.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.	Europe Electronic Drug Delivery Systems Market Snapshot
7.3.1.	U.K. 
7.3.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.3.1.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.	Germany
7.3.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion) 
7.3.2.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.	Rest of Europe
7.3.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.3.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.3.3.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.	Asia Electronic Drug Delivery Systems Market Snapshot
7.4.1.	China 
7.4.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.4.1.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.	India 
7.4.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.4.2.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.	Japan
7.4.3.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.3.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.4.3.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.	Rest of Asia Pacific
7.4.4.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.4.4.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.4.4.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.	Latin America Electronic Drug Delivery Systems Market Snapshot
7.5.1.	Brazil 
7.5.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.1.2.	 Type breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.5.1.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.	Mexico 
7.5.2.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.5.2.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.5.2.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
7.6.	Rest of The World 
7.6.1.	Middle East and Africa
7.6.1.1.	Market estimates & forecasts, 2016-2026 (USD Billion)
7.6.1.2.	Type breakdown estimates & forecasts, 2016-2026 (USD Billion)   
7.6.1.3.	 Indication breakdown estimates & forecasts, 2016-2026 (USD Billion)
Chapter 8.	Competitive Intelligence
8.1.	Company Market Share (Subject to Data Availability)
8.2.	Top Market Strategies
8.3.	Company Profiles
8.3.1.	 Merck Group (Germany)
8.3.1.1.	Overview
8.3.1.2.	Financial (Subject to Data Availability)
8.3.1.3.	Product Summary
8.3.1.4.	Recent Developments
8.3.2.	  Insulet Corporation (US)
8.3.3.	Bayer AG (Germany)
8.3.4.	Medtronic PLC  (Ireland)
8.3.5.	Novo Nordisk (Denmark)
8.3.6.	United Therapeutics Corporation (US)
8.3.7.	AstraZeneca (UK)
8.3.8.	Tandem Diabetes Care (US)
8.3.9.	Amgen (US)
Chapter 9.	Research Process
9.1.	Research Process
9.1.1.	Data Mining
9.1.2.	Analysis
9.1.3.	Market Estimation
9.1.4.	Validation
9.1.5.	Publishing
9.1.6.	Research Assumption

Global Electronic Drug Delivery Systems Market is valued approximately USD 7.2 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 8.7% over the forecast period 2019-2026. Drug delivery includes formulations, technologies, methods and systems for transferring an active pharmaceutical ingredient into the body. Electronic drug delivery systems are an advancement in the field which provides portable, interactive, wirelessly connected delivery systems and support patient administered therapy. The high prevalence of target diseases, the favorable reimbursement scenario in major markets, and advancements in technologies and designs of electronic drug delivery systems has increased the adoption of Electronic Drug Delivery Systems across the globe. However, the operation and functionality issues associated with the electronic devices will act as a restriction to the electronic drug delivery system market.

The regional analysis of global Electronic Drug Delivery Systems market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising prevalence of target diseases, the favorable reimbursement scenario, and approvals, and launches of innovative electronic drug delivery systems in the region. Whereas, Asia-Pacific is also anticipated to exhibit highest growth rate / CAGR over the forecast period 2019-2026. Factors such as increasing population along with increasing government expenditure on public health and research and development would create lucrative growth prospects for the Electronic Drug Delivery Systems market across Asia-Pacific region.

Major market player included in this report are:
Merck Group (Germany)
Insulet Corporation (US)
Bayer AG (Germany)
Medtronic PLC (Ireland)
Novo Nordisk (Denmark)
United Therapeutics Corporation (US)
Astrazeneca (UK)
Tandem Diabetes Care (US)
Amgen (US)
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type:
Electronic Wearable Infusion Pumps
Electronic Autoinjectors
Electronic Injection Pens
Electronic Inhalers
By Indication:
Diabetes
Multiple Sclerosis
Cardiovascular Disease
Asthma & COPD
Other Indications (growth hormone therapy, primary immunodeficiency disease, thalassemia, and Parkinson’s disease)
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Global Electronic Drug Delivery Systems Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investor


We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Full Name*

Business Email* (Please avoid generic email IDs such as gmail, yahoo)

Phone* (Please Affix Country Code)

Need specific market information? To get a customized report, please share your exact research requirements.



Loading…